期刊文献+

高龄老年肺炎65例临床分析 被引量:1

Clinical analysis on 65 cases with advanced agegerontal pneumonica
下载PDF
导出
摘要 目的探讨高龄老年肺炎的临床特点及诊治概况。方法分析2003年1月至2006年6月在我院住院的65例80岁以上高龄老年肺炎患者临床资料。结果既往有心、肺、神经系统等基础疾病者发病多。临床症状多表现为咳嗽(42例),咯痰(36例),喘息或呼吸困难(31例),中低热(25例),非特异症状多见,易出现并发症。X线胸片以小片状、斑点状阴影多见(42例);血气分析以低氧血症多见(40例),可出现呼吸衰竭(19例)。CAP及HAP两组痰培养以革兰阴性杆菌感染多见,HAP组真菌感染明显高于CAP组。结论高龄老年肺炎临床表现不典型且复杂,咳嗽、咯痰、喘息或呼吸困难、中低热是高龄老年肺炎的主要临床表现,高热、寒战、胸痛不明显,消化和神经系统的非特异症状多见。X线胸片、血气分析及痰培养等辅助检查对该病的及时诊治非常重要。重视基础疾病的治疗与全身情况的改善有助于提高临床治愈率、好转率。 Objective To inquire into the clinical characteristics and treatment of advanced agegerontal pneumonia.Methods The clinical data of 65 cases with advanced agesgerontal pneumonia whose age were over 80 years and stayed in our hospital from January 2003 to June 2006 was analyzed.Results The cases have the foundation diseases such as heart,lung and nervous system,etc are easy to fall ill.Clinical symptoms as follows:cough(42 cases),expectoration(36 cases),gasping or dyspnea(31 cases),middle or low fever(25 cases),and non-specific symptoms are frequent,also the complications.The X-ray sternite shows I fragm or mottling(42 cases)and blood gas analysis shows hypoxemia(40 cases),also appears respiratory failure(19 cases).The CAP and HAP sets's sputum culture can be seen much G-,fungous infection in HAP set is more than in CAP set.Conclusion The clinical manifestation of advanced agesgerontal pneumonia is atypical and multiplicity,and cough,expectoration,gasping or dyspnea,middle or low fever the clinical manifestations,but ardent fever,CFNS and chest complaint are not manifest.The non-specific of alimentary system and nervous system seen much.The auxiliary examinations,such as X-ray sternite,blood gas analysis and sputum culture,etc are very important to diagnose and treatment of advanced agesgerontal pneumonia.Treating foundation disease and improving sys.condition conduce to raise clinical improvement rate.
出处 《中国实用医药》 2007年第4期27-28,共2页 China Practical Medicine
关键词 高龄 肺炎 临床表现 辅助检查 Advanced age Pneumonia Clinical manifestation Auxiliary examination
  • 相关文献

参考文献4

二级参考文献24

  • 1李佩珍,柯会星,王洪冰.90例老年人肺炎病理与临床诊断[J].中华老年医学杂志,1995,14(3):156-158. 被引量:49
  • 2[1]Marston BJ,Plouffe JF,File TM, et al. Incidence of communityacquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The Community-Based Pneumonia Incidence Study Group. Arch Intern Med, 1997,157: 1709-1718.
  • 3[2]Jokinen C, Heiskanen L, Juvonen H, et al. Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland. Am J Epidemiol, 1993,137:977-988.
  • 4[3]Gross PA, Rapuano C, Adrignolo A, et al. Nosocomial infections: decade-specific risk. Infect Control, 1983,4:145.
  • 5[4]Marrie TJ, Blanchard W. A comparison of nursing homeacquired pneumonia and nursing home patients without pneumonia. J Am Geriatr Soc, 1997,45:50-55.
  • 6[5]Marrie TJ, Pneumonia in the elderly. Curr Opin Clin Med,1996,2: 192-197.
  • 7[6]Granton JT, Grossman RF. Community-acquired pneumonia in the elderly patient: clinical features, epidemiology, and treatment. Clin Chest Med, 1993,14:537.
  • 8[7]Woodhead M. Pneumonia in the elderly. J Antimicrob Chem other, 1994,34(Suppl ): 85-92.
  • 9[8]Lieberman D, Lieberman D, Schlaeffer F, et al. Communityacquired pneumonia in old age: a prospective study of 91patients admitted from home. Age Ageing, 1997,26:69-75.
  • 10[9]Fein AM, Feinsilver SH, Niederman MS. Atypical manifestations of pneumonia in the elderly. Clin Chest Med,1991,12:319.

共引文献123

同被引文献19

  • 1陈莉文,席玉胜,孟猛,魏春霞,殷先锋,谢潮鑫.氟康唑对院内深部真菌感染的预防观察与分析[J].中国现代医学杂志,2006,16(12):1861-1863. 被引量:12
  • 2Baddley J W.Clinical risk factors for invasive aspergillosis[J].Medical Mycology,2011,49( 1 ):7-12.
  • 3Shoham S,Marwaha S.Invasive Fungal Infections in the ICU[J].Intensive Care Med,2010,25(3):78-92.
  • 4Pfaller M A,Castanheira M,Lockhart S R,et al.Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant blood stream isolates of Candida glabrata[J].J Clin Microbiol,2012,50(4):1199-1203.
  • 5Grover C,Arora P,Manchanda V.Comparative evaluation of griseofulvin,terbinafine and fluconazole in the treatment of tineacapitis[J].Int J Dermatol,2012,51(4):455-458.
  • 6Szilagyi J,Foldi R,Gesztelyi R,et al.Comparison of the kidneyfungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole,amphotericin B and caspofungin in a temporarily neutropenic murine model[J].Chemotherapy,2012,58(2):159-164.
  • 7Wang H,Xiao M,Chen SC,et al.In vitrosusceptibilities of yeastspecies to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net ( CHIF-NET ) study[J].J Clin Microbiol,2012,50(12):3952-3959.
  • 8Chmiel J F,Aksamit T R,Chotirmall S H,et al.Antibiotic management of lung infections in cystic fibrosis.II.nontuberculous mycobacteria,anaerobic,and fungi[J].Ann Am Thorac Soc,2014,11(8):1298-1306.
  • 9Bicem C,Doluca M,Gulat S,et al.Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus[J].New Microbiologica,2012,35(3):327-334.
  • 10Limper A H,Knox K S,Sarosi GA,et al.An official American Thoracic Society statement : Treatment of fungal infection in adult pulmonary and critical care patients[J].Am J Respir CritCare Med,2011,183(1):96-128.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部